JOSEPH MCGUINNESS: Open Payments
NPI 1225373749 · LEPANTO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$669 in 18 payments from 11 companies in 2025. Trend: 2023 $125 · 2024 $197 · 2025 $669
Food & beverage: $669
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 4 | $379 |
| Merck Sharp & Dohme LLC | 2 | $54 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Lilly USA, LLC | 2 | $32 |
| ABBVIE INC. | 1 | $29 |
| Theratechnologies Inc. | 1 | $21 |
| ViiV Healthcare Company | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| CeQur Corporation | 1 | $15 |
Products named: Epclusa, PIFELTRO, JOURNAVX, Kerendia, JARDIANCE, MAVYRET, EGRIFTA, Biktarvy.
Industry payments across AR — which companies pay providers there.
